This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coutant, R. Articles by Limal, J.-M. Search for Related Content PubMed PubMed Citation Articles by Coutant, R. Articles by Limal, J.-M. Pubmed/NCBI databases Substance via MeSH

Growth and Adult Height in GH-Treated Children with Nonacquired GH Deficiency and Idiopathic Short Stature: The Influence of Pituitary Magnetic Resonance Imaging Findings

Departments of Pediatrics (R.C., S.R., J.M.L.) and Radiology (D.L.), University Hospital, 49000 Angers, France; and Department of Pediatrics, University Hospital (F.D., N.M.), 37000 Tours, France

Address all correspondence and requests for reprints to: Dr. Régis Coutant, Department of Pediatrics, University Hospital, 4 rue Larrey, 49000 Angers, France. E-mail: recoutant{at}chu-angers.fr

Abstract

We analyzed the final height of 146 short children with either nonacquired GH deficiency or idiopathic short stature. Our purpose was 1) to assess growth according to the pituitary magnetic resonance imaging findings in the 63 GH-treated children with GH deficiency and 2) to compare the growth of the GH-deficient patients with normal magnetic resonance imaging (n = 48) to that of 32 treated and 51 untreated children with idiopathic short stature (GH peak to provocative tests >10 µg/liter). The mean GH dose was 0.44 IU/kg·wk (0.15 mg/kg·wk), given for a mean duration of 4.6 yr.

Among the GH-deficient children, 15 had hypothalamic-pituitary abnormalities (stalk agenesis), all with total GH deficiency (GH peak <5 µg/liter). They were significantly shorter and younger at the time of diagnosis than those with normal magnetic resonance imaging, had better catch-up growth (+2.7 ± 0.9 vs. +1.3 ± 0.8 SD score; P < 0.01), and reached greater final height (-1.1 ± 1.0 vs. -1.7 ± 1.0 SD score; P < 0.05). Among patients with normal magnetic resonance imaging, there was no difference in catch-up growth and final height between partial and total GH deficiencies.

GH-deficient subjects with normal magnetic resonance imaging and treated and untreated patients with idiopathic short stature had comparable auxological characteristics, age at evaluation, and target height. Although they had different catch-up growth (+1.3 ± 0.8, +0.9 ± 0.6, and +0.7 ± 0.9 SD score, respectively; P < 0.01, by ANOVA), these patients reached a similar final height (-1.7 ± 1.0, -2.1 ± 0.8, and -2.1 ± 1.0 SD score, respectively; P = 0.13).

Pituitary magnetic resonance imaging findings show the heterogeneity within the group of nonacquired GH deficiency and help to predict the response to GH treatment in these patients. The similarities in growth between the GH-deficient children with normal magnetic resonance imaging and those with idiopathic short stature suggest that the short stature in the former subjects is at least partly due to factors other than GH deficiency.

This article has been cited by other articles:

				L. Dunkel Management of children with idiopathic short stature Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S35 - S38. [Abstract] [Full Text] [PDF]

				J. M. Lee, M. M. Davis, S. J. Clark, T. P. Hofer, and A. R. Kemper Estimated Cost-effectiveness of Growth Hormone Therapy for Idiopathic Short Stature Arch Pediatr Adolesc Med, March 1, 2006; 160(3): 263 - 269. [Abstract] [Full Text] [PDF]

				E. W. Leschek, S. R. Rose, J. A. Yanovski, J. F. Troendle, C. A. Quigley, J. J. Chipman, B. J. Crowe, J. L. Ross, F. G. Cassorla, W. F. Blum, et al. Effect of Growth Hormone Treatment on Adult Height in Peripubertal Children with Idiopathic Short Stature: A Randomized, Double-Blind, Placebo-Controlled Trial J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3140 - 3148. [Abstract] [Full Text] [PDF]

				M. G. F. Osorio, S. Marui, A. A. L. Jorge, A. C. Latronico, L. S. S. Lo, C. C. Leite, V. Estefan, B. B. Mendonca, and I. J. P. Arnhold Pituitary Magnetic Resonance Imaging and Function in Patients with Growth Hormone Deficiency with and without Mutations in GHRH-R, GH-1, or PROP-1 Genes J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5076 - 5084. [Abstract] [Full Text] [PDF]